Home NDC 60505-3220 Rivastigmine Tartrate
Product NDC 60505-3220
11-digit product format 605053220
Labeler code 60505
Product ID 60505-3220_35787807-49b2-6034-dcb0-36037574fb42
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rivastigmine Tartrate
Dosage form CAPSULE
Route ORAL
Labeler Apotex Corp.
Application ANDA091072
Marketing category ANDA
Marketing start 2013-02-20
Marketing end 0000-00-00
Substance RIVASTIGMINE TARTRATE
Active strength 2 mg/1
Pharmacologic classes Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 96 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091072-001 RIVASTIGMINE TARTRATE RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 A091072-002 RIVASTIGMINE TARTRATE RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 A091072-003 RIVASTIGMINE TARTRATE RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 A091072-004 RIVASTIGMINE TARTRATE RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091072-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2013-05-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091072-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2013-05-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091072-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2013-05-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091072-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2013-05-16 d06236e962d9…
Observed Orange Book normalized TE history# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RIVASTIGMINE TARTRATE ACTIVE INGREDIENT 9IY2357JPE RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 RIVASTIGMINE ACTIVE MOIETY PKI06M3IW0 RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] 1